- walked the public signup
- tracked the real cost
- read the fine print
REMEVi review
A genuinely transparent tiered-pricing shop — as low as $149/mo semaglutide or $199/mo tirzepatide on the annual plan — with press mentions and bilingual support, though the oral tablet's own pricing wasn't fully itemized.
- HSA / FSA-eligible
- Walked the public signup
- No insurance needed
REMEVi at a glance
- Semaglutide
- $149-219/mo depending on plan length
- Tirzepatide
- $199-319/mo depending on plan length
- Coverage
- All 50 states + DC
- Brand-name
- Compounded only
How I scored REMEVi
Every factor here comes from REMEVi's own pricing, its disclosures and the signup I walked, and the six add up to the 71/100 Mom-Tested Score on the same weighted six-factor method I use on every provider — never nudged by whether a provider pays us.
Scores low here: getting started asks more of your week than most.
Fair, once you've read past the plan structure or an intro rate.
Covers what most moms need, if not every option.
Wide coverage, but worth confirming your own state before you commit.
Support is the weakest part of this provider's score.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How I verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- remevihealth.com
$149 to $219 for semaglutide and $199 to $319 for tirzepatide, depending how long you commit, in all fifty states and DC. There's an oral tablet but no separate price for it, and no brand-name option at all.
What to expect when you sign up
I walked REMEVi's public signup funnel (August 2026) — a first-hand look at the flow. I don't create accounts, enter medical info, or check out, so this is what any visitor sees, not a patient outcome.
- 1Each drug's own page shows a 'From $X/mo' headline, then a plan-length picker (Monthly / 12-Week / 52-Week) with real prices for each tier
- 2The page states '6 services · $400+/mo bought separately' are bundled into the number
- 3A bilingual (English/Spanish) support model is advertised, plus press mentions (AP, USA Today, Fortune, Reuters) and Google/Trustpilot ratings
What I noticed
- Genuinely transparent tiered pricing — all three plan lengths for both molecules are visible without starting an intake
- The site explicitly states the per-month price 'never climbs with your dose,' a real flat-pricing claim
- No mention of a scheduled video call anywhere on the site; licensed in all 50 states plus DC per its own claim
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $219 | MonthlyPrice never climbs with dose. |
| Compounded semaglutide | $189 | 12-Week plan |
| Compounded semaglutide | $149 | 52-Week plan (best value)About $7.82/day on the monthly term equivalent, per the site's own framing. |
| Oral semaglutide | $219 | Daily tablet optionSame weekly-injection pricing structure offered as a daily oral tablet for needle-averse patients; exact oral tier pricing wasn't itemized separately on the page checked. |
| Compounded tirzepatide | $319 | Monthly |
| Compounded tirzepatide | $249 | 12-Week plan |
| Compounded tirzepatide | $199 | 52-Week plan (best value)Billed as $2,587 total, framed on-site as 'save $1,560' against the monthly rate. |
HSA and FSA usually work for this — worth checking your own plan. The prices here are what REMEVi's public disclosures showed at last review, and they change often; confirm the current number on REMEVi's own site.
What I like
- All three plan-length tiers for both molecules are visible on the public site, no intake required
- Explicitly states the price never climbs with dose — a real flat-pricing claim, not just a marketing line
- Bilingual (English/Spanish) support with WhatsApp, plus press mentions (AP, USA Today, Fortune, Reuters)
- Licensed in all 50 states plus DC; LegitScript and HIPAA badges displayed
The caveats
- No brand-name (FDA-approved) option
- The oral tablet option's own separate pricing tier wasn't itemized on the pages checked
- Cheapest tier requires a 52-week upfront commitment to reach $149/mo (sema) or $199/mo (tirz); the monthly rate is meaningfully higher at $219/$319
What I actually think of REMEVi
A genuinely transparent tiered-pricing shop — as low as $149/mo semaglutide or $199/mo tirzepatide on the annual plan — with press mentions and bilingual support, though the oral tablet's own pricing wasn't fully itemized. It runs about $149/month, and it's flat at every dose — toward the cheaper end of what I walked.
I look at REMEVi the way moms actually have to — not just the real monthly number, but nursing and pregnancy timing and canceling without a fight. That's the stuff a generic weight-loss review skips right over.
What REMEVi really costs
- Compounded semaglutide — Monthly: $219/mo
- Compounded semaglutide — 12-Week plan: $189/mo
- Compounded semaglutide — 52-Week plan (best value): $149/mo
- Oral semaglutide — Daily tablet option: $219/mo
- Compounded tirzepatide — Monthly: $319/mo
- Compounded tirzepatide — 12-Week plan: $249/mo
That's under the roughly $179 median I found across the providers I walked — real money back in the grocery budget.
Which meds REMEVi prescribes
REMEVi prescribes semaglutide and tirzepatide — the two with the strongest published weight-loss numbers, and having both on one account genuinely matters if insulin resistance is in the mix (which it often is with PCOS or after gestational diabetes), because that's when tirzepatide tends to be the better fit. These are compounded from a licensed pharmacy — that's why the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are, and it's worth knowing that going in.
There's a needle-free sublingual option too, which is a relief if injections are the thing stopping you — just set expectations honestly: the under-the-tongue versions are far less studied than the shots the trials actually used.
Who REMEVi is — and isn't — for
A good fit if…
- money is the actual barrier and you want a low, predictable number you can plan around.
- you might need to move between semaglutide and tirzepatide as your body and hormones shift.
- staying covered no matter where you are matters — a move for family shouldn't blow up your care.
Look elsewhere if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- you want to be able to cancel without a fight — the exit terms are the part of the fine print I'd read twice here.
- you'd rather a prescriber actually talk through nursing and pregnancy timing with you — that's what my #1 pick, CoreAge Rx, is built to do.
Can you trust it?
My confidence is middling — the core facts hold up, but some details (per-state availability, how the program really runs) aren't fully public. With any compounded GLP-1, the most useful thing you can do is confirm which licensed pharmacy fills it and what's actually in the formulation — I explain how I weigh oversight in the scoring method.
A standing caveat, because I'm a mom writing this and not your doctor: GLP-1 meds aren't established as safe during pregnancy or breastfeeding, and every label advises against it. Nothing here changes that — plan the timing with your own clinician.
So, would I use it?
REMEVi is a genuine budget play — weigh it against the picks below on nursing and pregnancy timing and canceling without a fight. For most moms, CoreAge Rx is still the stronger all-round fit — and you can see them side by side in this head-to-head.
The bottom line for moms
Best for: Moms who want to see every plan-length tier before committing and value bilingual (EN/ES) support.
If REMEVi isn't the one
Providers I have a referral relationship with, ordered by Mom-Tested Score — highest first. A fee never moves a score, but it does decide who shows up in this box, so it isn't everyone: my full ranking has every provider, paid or not.
- Visit CoreAge RxMom-Tested Score94/100ACoreAge RxMy #1 pick
The one I'd point a friend to first: I finished the intake in a single nap, the price on screen was the price I'd actually pay, and both semaglutide and tirzepatide were right there on one account.
- Visit Pallas HealthMom-Tested Score86/100B+
Pallas is one of the few places that will sell you either the cheap compounded route or the real brand-name pen without making you pick a provider first — compounded semaglutide works out to about $199 a month and tirzepatide about $299, while actual Zepbound, Ozempic, Wegovy and Mounjaro sit alongside them at cash-pay prices from $1,069. The price genuinely doesn't climb as you titrate, Pallas says so plainly on its own site, and the clinician, dose adjustments, check-ins and messaging are all inside that one number with no membership fee stacked on top. Two clinicians are named and both check out in the federal NPI registry, the LegitScript badge it displays is a real one, and it publishes an actual refund policy — full refund if a clinician turns you down, and a $5 processing fee if you cancel a qualifying payment — which is more paperwork than most of this market bothers with. The two things to know before you commit: it bills every 12 weeks in $597 and $897 chunks rather than monthly, and it never names its compounding pharmacy.
- Visit Trimi HealthMom-Tested Score85/100B
The price-first pick: some of the lowest flat, all-inclusive pricing I found, in all 50 states — great if the monthly number is your whole decision and you read the annual-prepay fine print before you sign.
Keep comparing REMEVi
Head-to-head & alternatives
REMEVi, answered
- How much does REMEVi cost?
- As I last checked, REMEVi's pricing starts around $149/month ($149-219/mo depending on plan length semaglutide, $199-319/mo depending on plan length tirzepatide). Confirm the current, all-in number on REMEVi's own site before you commit — these move.
- Is REMEVi okay to use while I'm breastfeeding?
- No — and that's true of every GLP-1, compounded or brand: none is established as safe in pregnancy or breastfeeding, and the labels say don't. REMEVi is no exception. Plan any GLP-1 for after weaning and talk the timing through with your own clinician. I'm a mom, not a doctor.
- Does REMEVi have both semaglutide and tirzepatide?
- Yes — REMEVi offers both. Tirzepatide's dual GIP/GLP-1 action is often the one clinicians reach for when insulin resistance drives weight, which matters if you've got PCOS or a history of gestational diabetes.
- Where does REMEVi land on your list?
- REMEVi scores 71/100 on the Mom-Tested Score (ranked #57), which weights the six things that actually matter when you're doing this around kids. My #1 pick, CoreAge Rx, leads the list — worth seeing how they stack up.
Pricing, states and verification reflect REMEVi's public disclosures at last review; the Mom-Tested Score is one mom's editorial judgment per the published method. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See my medical disclaimer and how I'm funded.